Purpose: To investigate the accuracy of predicted time-integrated activity coefficients (TIACs) in peptide-receptor radionuclide therapy (PRRT) using simulated dynamic PET data and a physiologically based pharmacokinetic (PBPK) model.
Methods: PBPK parameters were estimated using biokinetic data of 15 patients after injection of (152 +/- 15) MBq of In-111-DTPAOC (total peptide amount (5.78 +/- 0.25) nmol). True mathematical phantoms of patients (MPPs) were the PBPK model with the estimated parameters. Dynamic PET measurements were simulated as being done after bolus injection of 150 MBq Ga-68-DOTATATE using the true MPPs. Dynamic PET scans around 35 min p.i.(P-1), 4 h p.i.(P-2) and the combination of P-1 and P-2 (P-3 ) were simulated. Each measurement was simulated with four frames of 5 min each and 2 bed positions. PBPK parameters were fitted to the PET data to derive the PET-predicted MPPs. Therapy was simulated assuming an infusion of 5.1 GBq of Y-90-DOTATATE over 30 min in both true and PET-predicted MPPs. TIACs of simulated therapy were calculated, true MPPs (true TIACs) and predicted MPPs (predicted TIACs) followed by the calculation of variabilities v.
Results: For P1 and P2 the population variabilities of kidneys, liver and spleen were acceptable (v <10%). For the tumours and the remainders, the values were large (up to 25%). For P3, population variabilities for all organs including the remainder further improved, except that of the tumour (v > 10%).
Conclusion: Treatment planning of PRRT based on dynamic PET data seems possible for the kidneys, liver and spleen using a PBPK model and patient specific information. (C) 2017 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.
|Number of pages||7|
|Journal||Physica Medica: European journal of medical physics|
|Publication status||Published - Oct 2017|
- PBPK model
- PRRT treatment planning
- Dynamic PET
- PET noise model
- RECEPTOR RADIONUCLIDE THERAPY
- NEUROENDOCRINE TUMORS